Experiment 522516

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED

Compounds isolated

ESCULENTIC ACIDURS-12-EN-28-OIC ACID,3-BETA-(TRANS-PARA-COUMAROYL-OXY)-2-ALPHA-23-DIHYDROXY:URS-12-EN-28-OIC ACID,3-BETA-(CIS-PARA-COUMAROYL-OXY)-2-ALPHA-23-DIHYDROXY:

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
CARCINOGENESIS INHIBITION
Administration routeINTRAGASTRIC
OrganismEmpty organism
CitationTOKUDA,H: TAKEBAYASHI,K: KAWASHIMA,A: NIWANO,M: MIMURA,M: TAKAHARA,Y:. (1994). LUNG CANCER INHIBITORS CONTAINING TRITERPENES.. ()
Amount utilized
Compound isolated
DiseaseVS.4-NITROQUINOLINE 1-OXIDE INDUCED CARCINOGENESIS.
Dose amount25.0 MCG
Number1
Qualitative resultACTIVE
AnimalMOUSE
Per unitML
Dose expressionDOSE